Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Finasteride shows promise for female hair loss, but more research needed.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

A woman with severe angioedema improved significantly after treatment with rituximab.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Some nonsurgical hair loss treatments are effective, especially if started early.

Hair restoration techniques like follicular unit transplant surgery and follicular unit extraction are effective, with ideal graft placement density between 20-30 units per cm². Medications like Minoxidil and Finasteride can help maintain and regrow hair.

Certain drugs change freshwater snail shells to a "banana" shape.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Finasteride helps hair growth but may cause sexual side effects and depression.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Low-dose dutasteride effectively and safely promotes hair growth in men.

Pharmacists play a crucial role in patient care and public health.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.